Tempest Therapeutics Inc

General ticker "TPST" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $22.1M

Tempest Therapeutics Inc does not follow the US Stock Market performance with the rate: -35.7%.

Estimated limits based on current volatility of 4.5%: low 0.71$, high 0.77$

Factors to consider:

  • Current price 70.1% below estimated low
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.38$, 6.53$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.77$, 4.96$]

Financial Metrics affecting the TPST estimates:

  • Negative: Non-GAAP EPS, $ of -1.91 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -32.74 <= 2.35
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Interest expense per share, $ of 0.09 <= 0.14

Similar symbols

Short-term TPST quotes

Long-term TPST plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $26.99MM $34.64MM $29.16MM
Operating Income $-26.99MM $-34.64MM $-29.16MM
Non-Operating Income $-1.32MM $-1.07MM $-0.33MM
Interest Expense $1.28MM $1.62MM $1.45MM
R&D Expense $17.17MM $22.53MM $17.50MM
Income(Loss) $-28.30MM $-35.71MM $-29.49MM
Profit(Loss) $-28.30MM $-35.71MM $-29.49MM
Stockholders Equity $36.12MM $18.11MM $26.77MM
Inventory $1.58MM $0.00MM $0.00MM
Assets $73.24MM $46.09MM $51.60MM
Operating Cash Flow $-25.96MM $-31.07MM $-27.36MM
Capital expenditure $0.14MM $0.56MM $0.17MM
Investing Cash Flow $-0.10MM $-0.56MM $-0.17MM
Financing Cash Flow $59.06MM $11.40MM $35.60MM
Earnings Per Share* $-7.80 $-3.18 $-1.91

* EPS are Split Adjusted, recent splits may be reflected with a delay.